Bench strength ranging from strategic CFO leadership to plan implementation, technical accounting, financial reporting and investor relations
We have extensive knowledge of the capital needs, financing paths and investor interests in life sciences, including strategies for financing in challenging markets. Whether embarking on a Series A round or contemplating an IPO, we can provide strategic and operational leadership along with the supporting skill sets to augment your internal resources or act as your full finance team throughout the process and beyond. The knowledge, perspective and relationships that we bring to financing strategy and execution are all rooted in life science sector experience.
Key Considerations
Your financing approach should be informed by the answers to several critical questions.
- What is your desired end game? To advance your drug or product to commercialization? To be acquired? Your long-term vision should dictate your financing strategy.
- How much should you raise? How long will that last and what can be achieved in that time? Start by thinking about value creation and the capital required to reach your next milestone.
- When is it time to raise more capital? It’s important to achieve valuation step-up with each successive financing. We generally advise clients to finance through their next valuation inflection point – whether the achievement of clinical results or other meaningful progress – plus a 6-month buffer to gear up for the next financing.
How Danforth Can Help
Strategic leadership
Our bench includes strategic CFOs with decades of experience guiding equity and debt financings for private and public life science companies. This experience spans wide-ranging financing paths, including venture capital funding, private placements and PIPE transactions, IPOs, SPACs and reverse mergers. Our advisory is shaped by understanding investor preferences and trends, value creation and capital requirements for advancement.
Knowledge of financing options
We understand the full spectrum of options available to life science companies, the pros and cons of each, and how they might apply to your specific business.
Well-established network
We have deep and longstanding relationships with the life science investor community, bankers, attorneys, valuation firms and other relevant providers – sparing you the search and vetting process.
Investor relations
We work with companies to optimize the success of the financing process – effectively communicating the company’s value proposition for investors, developing the pitch deck, determining the right time to launch a financing, targeting the right investors and supporting with outreach and execution. Learn more here.
Operational implementation
Whether as a CFO or resources to supplement your internal team, we can put your financing plan into action. These activities include diligence support, negotiations and introductions to buy and sell side participants. Our FP&A specialists can also prepare a dynamic pro-forma cap table to inform stakeholders’ pre-financing decision making.
Technical accounting and reporting
We have a dedicated Accounting and Reporting Advisory team able to meet the complex accounting and reporting requirements of all types of financing transactions. These requirements may include audit support, technical documentation, IPO support and SEC reporting and managed services.
We’re here to help
Contact us to schedule a conversation about financing strategy and execution